Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
PhoreMost
PhoreMost
Activities:
Research & Development
X
LinkedIn
Trending Articles
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Adare expands global handling & packaging capabilities
The company will have enhanced compaction, milling, bin blending and tablet compression capabilities in Philadelphia, Ohio and Milan
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
PhoreMost partners with Roche on multi-project drug target collab
PhoreMost will deploy its in-house expertise and next-generation phenotypic screening platform, SITESEEKER
Manufacturing
PhoreMost expands into Cambridge facility at Unity Campus
This relocation places the company in close proximity to numerous life science and technology organisations
Research & Development
NeoCura and PhoreMost announce collaboration on cancer therapeutics
As part of the collaboration, PhoreMost's Siteseeker phenotypic screening platform and NeoCura's full-process RNA drug design platform will be used
Pharmaceutical
PhoreMost fills Director roles with an OBE and a PhD
UK biopharma has appointed Dr Beech as a Non-Executive Director and Dr Cross as Senior Director of Technology
Drug Delivery
Boehringer chooses PhoreMost for new drug discovery collaboration
PhoreMost's Siteseeker platform will be deployed to identify novel targets for Boehringer’s programmes
Media
PhoreMost and o2h discovery collaborate
Collaboration will aim to progress first-in-class drug discovery programmes
Research & Development
Funding to support novel cancer immunotherapy programme
Award of the grant funds expanded operations and recognises innovative drug discovery programme
Subscribe now